Seeking Alpha

GENZ Transcripts Search Results

Results 1-10 for renvela (out of 12)
Refine your search:

You can use: AND, NOT, OR, " " (exact phrase)

Search across all Transcripts:

You can use: AND, NOT, OR, " " (exact phrase)


  • Genzyme Corporation Q2 2009 Earnings Call Transcript 22 Jul, 2009
    ... metabolic, renal area increased by 4% to $243 million. This is due to increases in both Renagel and Renvela as well as continued strong performance of Thyrogen. Thyrogen increased by 9% on a year over year basis. The ...
  • Genzyme Corporation Q1 2009 Earnings Call Transcript 22 Apr, 2009
    ... Butler will talk about Renagel/Renvela with immersion briefly before we ... very strong, well differentiated product. Renvela was approved in Europe. Recommended ... inventory levels for Renagel and Renvela are in the U.S., given ...
  • Genzyme Q4 2008 Earnings Call Transcript 11 Feb, 2009
    ... that will impact throughout this year. Renvela, we would expect its first half ... remained strong. The launch of Renvela in U.S has clearly allowed us ... discussions in Europe continue for Renvela as well as our discussions ...
  • Genzyme Corporation Q3 2008 Earnings Call Transcript 22 Oct, 2008
    ... committee meeting, I believe, in December. Renvela, the CKD story that I'm ... launches expenses associated with both Renvela and Mozobil. And as I ... ? John Butler Thanks, Henri. The Renvela launch has continued to accelerate ...
  • Genzyme Corp. Q2 2008 Earnings Call Transcript 23 Jul, 2008
    ... expect to begin introduction of Renvela in 2009 internationally. Expanding our ... get to a point where Renvela is the product that we ... marketing, particularly in the global Renvela launch, Mozobil pre-launch activities, things ...
  • Genzyme Corp. Q1 2008 Earnings Call Transcript 23 Apr, 2008
    ... access to that market. We launched Renvela for dialysis in the beginning of ... but qualitative research tells us that Renvela will allow us some expansion of ... past the first stage of introducing Renvela, they will get back to ...
  • Genzyme Corp. Q4 2007 Earnings Call Transcript 13 Feb, 2008
    ... development plans; timetable for Clolar, Renvela, Synvisc-ONE, mipomersen, alemtuzumab and Mozobil; ... been gearing up for the Renvela launch since receiving approval. Final ... of whether it's Renvela or Renagel. It's ...
  • Genzyme Q3 2007 Earnings Call Transcript 24 Oct, 2007
    ... plans and regulatory action estimates, including for Renvela, Clolar, Campath, Mozobil, Genz-112638, Myozyme our manufacturing. ... on Monday that the FDA had approved Renvela, sevelamer carbonate, to control phosphorus in ...
  • Genzyme Q2 2007 Earnings Call Transcript 25 Jul, 2007
    ... the late stage development portfolio, which included Tolevamer, Renvela, Synvisc-One, Myozyme and Mozobil. Now as I mentioned ... is to leverage the other benefits sevelamer Renvela brings, like the LDL lowering, the binding ...
  • Genzyme Q2 2007 Earnings Call Transcript 25 Jul, 2007
    ... development portfolio, which included Tolevamer, Renvela, Synvisc-One, Myozyme and Mozobil. Now, ... that was being driven by Renvela is access to a much ... have, but include products like Renvela and Synvisc-One and Hylastan as ...
Search GENZ Transcripts:

You can use: AND, NOT, OR, " " (exact phrase)

Most Popular Searches

in GENZ transcripts

Other Transcripts
from the Biotech Sector
  1. Arrowhead Research Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
  2. Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
  3. Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
To search across transcripts, find the most recent and most popular and view by sector, try: Seeking Alpha's Transcript Center